Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma.

TP MacGregor; R Carter; RS Gillies; JM Findlay; C Kartsonaki; F Castro-Giner; N Sahgal; LM Wang; R Chetty; ND Maynard; JB Cazier; F Buffa; PJ McHugh; RA Sharma

doi:10.1038/s41598-018-24232-2

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma.

TP MacGregor, R Carter, RS Gillies, JM Findlay, C Kartsonaki, F Castro-Giner, N Sahgal, LM Wang, R Chetty, ND Maynard, JB Cazier, F Buffa, PJ McHugh, RA Sharma

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Scientific Reports
DOIs	https://doi.org/10.1038/s41598-018-24232-2
Publication status	Published - May 2018

Access to Document

10.1038/s41598-018-24232-2

Cite this

MacGregor, TP., Carter, R., Gillies, RS., Findlay, JM., Kartsonaki, C., Castro-Giner, F., Sahgal, N., Wang, LM., Chetty, R., Maynard, ND., Cazier, JB., Buffa, F., McHugh, PJ., & Sharma, RA. (2018). Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma. Scientific Reports. https://doi.org/10.1038/s41598-018-24232-2

@article{084435d5ff2043268c33a4ea816d3279,

title = "Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma.",

author = "TP MacGregor and R Carter and RS Gillies and JM Findlay and C Kartsonaki and F Castro-Giner and N Sahgal and LM Wang and R Chetty and ND Maynard and JB Cazier and F Buffa and PJ McHugh and RA Sharma",

year = "2018",

month = may,

doi = "10.1038/s41598-018-24232-2",

language = "English",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

}

MacGregor, TP, Carter, R, Gillies, RS, Findlay, JM, Kartsonaki, C, Castro-Giner, F, Sahgal, N, Wang, LM, Chetty, R, Maynard, ND, Cazier, JB, Buffa, F, McHugh, PJ & Sharma, RA 2018, 'Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma.', Scientific Reports. https://doi.org/10.1038/s41598-018-24232-2

TY - JOUR

T1 - Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma.

AU - MacGregor, TP

AU - Carter, R

AU - Gillies, RS

AU - Findlay, JM

AU - Kartsonaki, C

AU - Castro-Giner, F

AU - Sahgal, N

AU - Wang, LM

AU - Chetty, R

AU - Maynard, ND

AU - Cazier, JB

AU - Buffa, F

AU - McHugh, PJ

AU - Sharma, RA

PY - 2018/5

Y1 - 2018/5

UR - http://europepmc.org/abstract/med/29739952

U2 - 10.1038/s41598-018-24232-2

DO - 10.1038/s41598-018-24232-2

M3 - Article

C2 - 29739952

SN - 2045-2322

JO - Scientific Reports

JF - Scientific Reports

ER -